Tarsus Pharmaceuticals, Inc.

NASDAQ (USD): Tarsus Pharmaceuticals, Inc. (TARS)

Last Price

48.11

Today's Change

+1.37 (2.93%)

Day's Change

46.38 - 48.33

Trading Volume

433,648

Overview

Market Cap

1 Billion

Shares Outstanding

38 Million

Avg Volume

757,846

Avg Price (50 Days)

50.44

Avg Price (200 Days)

36.62

PE Ratio

-12.83

EPS

-3.75

Earnings Announcement

25-Feb-2025

Previous Close

46.74

Open

47.67

Day's Range

46.38 - 48.335

Year Range

20.082 - 57.14

Trading Volume

433,648

Price Change Highlight

1 Day Change

2.93%

5 Day Change

1.73%

1 Month Change

-9.07%

3 Month Change

26.61%

6 Month Change

77.27%

Ytd Change

-12.77%

1 Year Change

89.56%

3 Year Change

142.61%

5 Year Change

133.77%

10 Year Change

133.77%

Max Change

133.77%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment